RECOVER is a research initiative funded by the National Institutes of Health (NIH) that seeks to understand, prevent, and treat PASC, including Long COVID. PASC stands for post-acute sequelae of SARS-CoV-2 and is a term scientists are using to study the potential consequences of a SARS-CoV-2 infection.

RECOVER Boston includes the five Boston medical centers that are taking part in the national RECOVER effort to investigate PASC.

Long COVID, also known as Post-COVID, Long-haul COVID or Post-acute COVID, is a range of new, lingering, or returning symptoms that patients experience four or more weeks after an initial SARS-CoV-2 infection.

What does recovery from SARS-CoV-2 infection look like among different groups?

How many people continue to have symptoms after acute infection?

How many people develop new symptoms after acute infection?

What causes these health effects?

Why do some people develop these health effects while others do not?

Does SARS-CoV-2 infection trigger changes in the body that increase the risk of other conditions, such as chronic lung, heart, or brain disorders?

This study is funded by the National Institutes of Health (NIH)

To contact our team, please scroll to the bottom of this page and click the white “Contact Our Study Teams” button.